MRNA Jul 2024 130.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

27.45

-1.30

(-4.52%)

As of 01:02PM EDT. Market open.

Loading interactive chart…

Yahoo Finance
Novavax's stock surges almost 300% in the past month
Novavax stock is soaring on news the FDA set a deadline by which to approve or reject its COVID-19 vaccine.
Barrons.com
New Covid Boosters Get a Thumbs-Up From FDA. Vaccine Stocks Are Wavering.
Drugmakers are aiming to launch this year’s shots by the beginning of September but have been waiting on the FDA to decide which strain of the virus to target. At their meeting on Wednesday, the FDA’s advisers nevertheless recommended that this year’s shots target JN.1, saying they expect a JN.1 shot to offer sufficient protection against the strain’s descendants.
Zacks
Halozyme Therapeutics (HALO) Up 8.7% Since Last Earnings Report: Can It Continue?
Halozyme Therapeutics (HALO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.